Itraconazole

Major

Itraconazole Asciminib Scemblix Reduced asciminib exposure and reduced efficacy of asciminib Details Itraconazole Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation and torsade de pointes Details Itraconazole Atogepant Qulipta Increased atogepant exposure Details Itraconazole Avapritinib Ayvakit Increased avapritinib exposure and increased incidence and severity of adverse reactions Details Itraconazole Avatrombopag Doptelet Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse effects Details Itraconazole Azathioprine Azasan An increased risk of hepatotoxicity Details Itraconazole Azithromycin AzaSite An increased risk of QT interval prolongation and torsade de pointes Details Itraconazole Belumosudil Rezurock Explained Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse effects Details Itraconazole Betrixaban Bevyxxa® Increased betrixaban exposure and increased risk of bleeding Details Itraconazole Cabergoline Dostinex® Increased cabergoline exposure and an increased risk of cabergoline-related adverse effects Details Itraconazole Atorvastatin Atorvaliq Increased atorvastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Itraconazole Cariprazine Vraylar Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Itraconazole Abiraterone Abirtega Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse effects Details Itraconazole Afatinib Gilotrif Increased exposure of afatinib Details Itraconazole Amlodipine Amvaz® Increased amlodipine exposure and an increased risk of congestive heart failure Details Itraconazole Anagrelide Agrylin Increased risk of QT interval prolongation Details Itraconazole Axitinib Inlyta Increased axitinib exposure Details Itraconazole Beclomethasone Nasal Spray Beconase Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Itraconazole Beclomethasone Oral Inhalation Beclovent® Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Itraconazole Bedaquiline Sirturo Increased bedaquiline exposure and an increased risk of QT interval prolongation Details Itraconazole Bortezomib Boruzu Increased bortezomib exposure and an increased risk of bortezomib-related adverse effects Details Itraconazole Bosutinib Bosulif Increased bosutinib exposure Details Itraconazole Brentuximab Vedotin Injection Adcetris Increased brentuximab vedotin exposure and an increased risk of brentuximab vedotin-related adverse effects Details Itraconazole Brexpiprazole Rexulti Increased brexpiprazole exposure Details Itraconazole Brigatinib Alunbrig Increased brigatinib exposure Details Itraconazole Budesonide Entocort Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Itraconazole Budesonide Nasal Spray Rhinocort Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Itraconazole Budesonide Oral Inhalation Pulmicort Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Itraconazole Busulfan Injection Busulfex Increased busulfan exposure and an increased risk of busulfan-related adverse effects Details Itraconazole Cabazitaxel Injection Jevtana Increased cabazitaxel exposure Details Itraconazole Cabozantinib Cabometyx Increased cabozantinib exposure Details Itraconazole Cabozantinib (Thyroid Cancer) Cabometyx Increased cabozantinib exposure Details Itraconazole Calcifediol Rayaldee Altered serum levels of calcifediol Details Itraconazole Capmatinib Tabrecta Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse effects Details Itraconazole Chloroquine Aralen® Increased risk of QT-interval prolongation Details Itraconazole Ciclesonide Nasal Spray Omnaris Increased ciclesonide exposure and an increased risk of ciclesonide-related adverse effects Details Itraconazole Ciclesonide Oral Inhalation Alvesco Increased ciclesonide exposure and an increased risk of ciclesonide-related adverse effects Details Itraconazole Clindamycin Injection ANTIROBE Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse effects Details Itraconazole Clindamycin Topical C/T/S® Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse effects Details Itraconazole Clindamycin Vaginal Cleocin Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse effects Details